Abstract Multiple system atrophy (MSA) is a fatal, rapidly progressive atypical parkinsonism that responds poorly to Parkinson’s disease (PD) medications, and diagnostic precision remains a critical unmet need. Earlier, accurate diagnosis would give patients realistic prognostic expectations and enable timely clinical-trial enrollment. We sought plasma biomarkers discriminating MSA from PD.
Koji Ueda
As seen in:
MSN,
MSN Canada,
MSN UK,
Fox News,
MSN España,
Nature,
The Independent (UK),
The Washington Post,
TIME,
USA Today
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Koji
Contact Koji, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack